Despite Trump's chloroquine hype, we're still waiting for a 'game changer' cure for COVID-19 [Los Angeles Times (CA)]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Los Angeles Times
It’s been nearly four weeks since the U.S. Food and Drug Administration gave an emergency blessing to the use of two anti-malaria drugs for the treatment of COVID-19, setting the stage for the stockpiling and distribution of millions of doses. But so far, the drugs have fallen far short of President Trump’s repeated promotion of them as potential “game changers.” For the most part, studies and clinical experience haven’t shown the hoped-for results of lowered death rates or quicker clearing of the novel coronavirus with chloroquine or hydroxychloroquine. The drugs’ side effects — most notably, dangerous heart problems — were troubling enough that a research effort in Brazil changed its protocol to avoid giving high doses, and Sweden has warned hospitals against using it to treat COVID-19. A newly released analysis of its use in veterans hospitals found no benefit. In fact, patients treated with hydroxychloroquine plus the usual therapies were more likely to die than those who received
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]Yahoo! Finance
- Whey Protein Market To Reach USD 16.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences first-quarter profit beats estimates on heart devices strength [Reuters]Reuters
- Europe High Pressure Non-Compliant Balloon Catheter Market Size to Worth USD 1,801.5 by 2032: Astute Analytica [Yahoo! Finance]Yahoo! Finance
- Global Bionic Devices Industry Research, 2023-2024 & 2030: Addressing Diverse Healthcare Needs Worldwide to Sustain Growth and Fuel Develoments [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website